Melitracen
Clinical data | |
---|---|
Trade names | Adaptol, Dixeran, Melixeran, Thymeol, Trausabun |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral, intramuscular injection |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Melitracen (brand names Melixeran, Trausabun) is a tricyclic antidepressant (TCA), for the treatment of depression and anxiety.[1][2][3][4] In addition to single drug preparations, it is also available as Deanxit, marketed by Lundbeck, a combination product containing both melitracen and flupentixol.[5][6][7][8]
The pharmacology of melitracen has not been properly investigated and is largely unknown, but it is likely to act in a similar manner to other TCAs. Indeed, melitracen is reported to have imipramine and amitriptyline-like effects and efficacy against depression and anxiety, though with improved tolerability and a somewhat faster onset of action.[9][10]
See also
References
- ISBN 3-88763-075-0.
- ISBN 0-412-54090-8.
- ISBN 0-911910-13-1.
- ISBN 978-3-527-31058-6.
- ISBN 3-7692-2114-1.
- PMID 6670581.
- PMID 3917005.
- S2CID 40714136.
- ISBN 978-0-444-53266-4.
- ISBN 0-12-040505-9.